Deutsche Bank cut its price target for Biohaven to $23 from $26 but still recommends buying the stock.

BHVN · Biohaven Ltd.

The AI's read

The lower target suggests the bank sees less share value than before. Keeping its Buy rating points the other way. The update gives no new company results or other details about Biohaven's business, so it does not change the company's outlook.